← Back to directory

Stephan Petersenn

Researcher Next ID · RN-030300

Researcher · Medicine

Endokrinologikum

Hamburg, Estonia

Not currently recruitingFunding unknown
Works count
341
Citation count
14,217
H-index
59
i10-index
152

Research interests

Medicine
Pituitary Gland Disorders and Treatments
Adrenal and Paraganglionic Tumors
Growth Hormone and Insulin-like Growth Factors
Adrenal Hormones and Disorders
Neuroendocrine Tumor Research Advances

Publications

  • Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

    Nature Reviews Endocrinology · 2023 · https://doi.org/10.1038/s41574-023-00886-5

  • Consensus on criteria for acromegaly diagnosis and remission

    Pituitary · 2023 · 10.1007/s11102-023-01360-1

  • Consensus on diagnosis and management of Cushing's disease: a guideline update

    White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · 2021

  • Multidisciplinary management of acromegaly: A consensus

    Reviews in Endocrine and Metabolic Disorders · 2020 · 10.1007/s11154-020-09588-z

  • A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update

    The Journal of Clinical Endocrinology & Metabolism · 2019 · https://doi.org/10.1210/clinem/dgz096

  • Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

    European Journal of Endocrinology · 2018 · 10.1530/eje-17-0933

  • Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma

    Hypertension · 2017 · https://doi.org/10.1161/hypertensionaha.117.09975

  • Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

    The Lancet Diabetes & Endocrinology · 2017 · 10.1016/s2213-8587(17)30326-1

  • European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

    European Journal of Endocrinology · 2017 · 10.1530/eje-17-0796

  • Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention

    JAMA Oncology · 2017 · https://doi.org/10.1001/jamaoncol.2017.0223

  • THERAPY OF ENDOCRINE DISEASE: Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence

    European Journal of Endocrinology · 2015 · 10.1530/eje-14-0883

  • High variability in baseline urinary free cortisol values in patients with Cushing's disease

    Clinical Endocrinology · 2013 · 10.1111/cen.12259

  • Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

    The Journal of Clinical Endocrinology & Metabolism · 2013 · https://doi.org/10.1210/jc.2013-3318

  • A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

    New England Journal of Medicine · 2012 · 10.1056/nejmoa1105743

  • 68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors

    Journal of Nuclear Medicine · 2011 · 10.2967/jnumed.111.091165

  • Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial

    The Journal of Clinical Endocrinology & Metabolism · 2010 · 10.1210/jc.2009-2272

  • Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers

    The Journal of Clinical Endocrinology & Metabolism · 2010 · https://doi.org/10.1210/jc.2010-0803

  • Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients

    Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-09-1237

  • Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial

    The Journal of Clinical Endocrinology & Metabolism · 2008 · 10.1210/jc.2008-1008

  • Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement

    The Journal of Clinical Endocrinology & Metabolism · 2008 · https://doi.org/10.1210/jc.2007-2734

  • A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR ® (long‐acting repeatable octreotide) in the primary therapy of patients with acromegaly

    Clinical Endocrinology · 2007 · 10.1111/j.1365-2265.2007.02825.x

  • Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry

    European Journal of Endocrinology · 2007 · 10.1530/eje.1.02326

  • Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury

    European Journal of Endocrinology · 2006 · 10.1530/eje.1.02071

  • Posterior retroperitoneoscopic adrenalectomy—results of 560 procedures in 520 patients

    Surgery · 2006 · 10.1016/j.surg.2006.07.039

  • Laparoscopic and Retroperitoneoscopic Treatment of Pheochromocytomas and Retroperitoneal Paragangliomas: Results of 161 Tumors in 126 Patients

    World Journal of Surgery · 2006 · 10.1007/s00268-005-0373-6

Current projects

    No projects listed.